Plant Bioscience Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Plant Bioscience Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10925
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Plant Bioscience Ltd (PBL) is a technology management company that offers services in plant, food and microbial science. The company provides intellectual property management, patent advisory, licensing and technology transfer services. It offers patient consultation and management services, which include IP identification and assessment, IP strategy definition and implementation, initial patent application drafting, IP portfolio management, and IP portfolio assessment and due diligence. PBL develops a range of technologies for licensing in plant science, general biotechnology, health and medicine, microbiology, nutritional and food technology industries. It offers assistance and advice related to protecting and commercialising new technology for researcher or research organization. PBL works in partnership with research institutes and universities. PBL is headquartered in Norwich, the UK.

Plant Bioscience Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Licensing Agreements 9
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 9
Plant Bioscience Enters into Licensing Agreement with Centro Nacional de Biotecnologia 10
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 11
Alnylam Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe Patent 12
Plant Bioscience Ltd – Key Competitors 13
Plant Bioscience Ltd – Key Employees 14
Plant Bioscience Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 9
Plant Bioscience Enters into Licensing Agreement with Centro Nacional de Biotecnologia 10
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 11
Alnylam Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe Patent 12
Plant Bioscience Ltd, Key Competitors 13
Plant Bioscience Ltd, Key Employees 14
Plant Bioscience Ltd, Joint Venture 15

List of Figures
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Plant Bioscience Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Toei Animation Co., Ltd. (4816):企業の財務・戦略的SWOT分析
    Toei Animation Co., Ltd. (4816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • Sembcorp Industries Ltd (U96):石油・ガス:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • TRACON Pharmaceuticals Inc (TCON):企業の財務・戦略的SWOT分析
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TJ004309, TRC253, TRC694, and TRC205. Its le …
  • Kenzo Parfums NA, LLC:企業の戦略・SWOT・財務情報
    Kenzo Parfums NA, LLC - Strategy, SWOT and Corporate Finance Report Summary Kenzo Parfums NA, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bridgelux Inc:電力:M&Aディール及び事業提携情報
    Summary Bridgelux Inc (Bridgelux) is a power products manufacturer that designs and markets light-emitting diode technologies and solutions. The company offers products such as Decor series, H series, OLM series, V series, Vero series, SMD products, LED chips and BXRA3 series bulbs. It also provides …
  • Tokuyama Corp (4043)
    Tokuyama Corp (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Kingspan Group Plc:企業の戦略・SWOT・財務情報
    Kingspan Group Plc - Strategy, SWOT and Corporate Finance Report Summary Kingspan Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • vTv Therapeutics Inc (VTVT):製薬・医療:M&Aディール及び事業提携情報
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • HepQuant Llc:製品パイプライン分析
    Summary Hepquant LLC (Hepquant) is a medical device company that provides diagnostic products. The company develops and markets products for measuring liver function. It offers products such as hepquant-stat, hepquant-shunt, and hepquant-flow. Hepquant’s hepquant-STAT is used in screening assay to i …
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Idogen AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Idogen AB (Idogen) is a biotechnology company that develops tolerogenic vaccines which reprogram the immune system of paitents. The company provides product portfolio such as antibodies for autoimmune diseases, organ rejection after transplantation and several other disease conditions. It de …
  • PowerFilm, Inc.:企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • BioGaia AB (BIOG B)-製薬・医療分野:企業M&A・提携分析
    Summary BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), str …
  • ONEOK Partners LP:石油・ガス:M&Aディール及び事業提携情報
    Summary ONEOK Partners, L.P. (ONEOK Partners), a subsidiary of Oneok, Inc., is a midstream energy company. The company carries out gathering, processing, and storage and transportation of natural gas. It operates through master limited partnerships. ONEK Partners owns natural gas liquids (NGL) syste …
  • Alliant Insurance Services, Inc.:企業のM&A・事業提携・投資動向
    Alliant Insurance Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alliant Insurance Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • University of Tennessee Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary University of Tennessee Research Foundation (UTRF), a subsidiary of University of Tennessee is a non profit organization that promotes research and education. The organization offers agriculture, chemistry and materials; energy, animal health, engineering, human health, research tools and so …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆